Review article · 2024 · Open access

Precision-engineered PROTACs minimize off-tissue effects in cancer therapy

Jianghua Shi, Luo Wang, Xuanwei Zeng, Chengzhi Xie, Zhaowei Meng, Anahit Campbell, Lulu Wang, Heli Fan, Huabing Sun

Frontiers in Molecular Biosciences, 11, 1505255 · Published 22 November 2024 · DOI 10.3389/fmolb.2024.1505255

Open full textCite this paper

In brief

“Precision-engineered PROTACs minimize off-tissue effects in cancer therapy” is a 2024 review article by Jianghua Shi and 8 co-authors, published in Frontiers in Molecular Biosciences. OpenAlex counts 40 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Molecular Biosciences.

Citations
40
Most cited in
2026 (26)
Field-weighted impact
1.30
References
86
Authors
9

Abstract

Proteolysis-targeting chimeras (PROTACs) offer a groundbreaking approach to selectively degrade disease-related proteins by utilizing the ubiquitin-proteasome system. While this strategy shows great potential in preclinical and clinical settings, off-tissue effects remain a major challenge, leading to toxicity in healthy tissues. This review explores recent advancements aimed at improving PROTAC specificity, including tumor-specific ligand-directed PROTACs, pro-PROTACs activated in tumor environments, and E3 ligase overexpression strategies. Innovations such as PEGylation and nanotechnology also play a role in optimizing PROTAC efficacy. These developments hold promise for safer, more effective cancer therapies, though challenges remain for clinical translation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shi, J., Wang, L., Zeng, X., Xie, C., Meng, Z., Campbell, A., Wang, L., Fan, H., & Sun, H. (2024). Precision-engineered PROTACs minimize off-tissue effects in cancer therapy. Frontiers in Molecular Biosciences, 11, 1505255. https://doi.org/10.3389/fmolb.2024.1505255

MLA 9

Shi, Jianghua, et al. “Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.” Frontiers in Molecular Biosciences, vol. 11, 2024, p. 1505255. https://doi.org/10.3389/fmolb.2024.1505255.

Chicago

Shi, Jianghua, Luo Wang, Xuanwei Zeng, Chengzhi Xie, Zhaowei Meng, Anahit Campbell, Lulu Wang, Heli Fan, and Huabing Sun. 2024. “Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.” Frontiers in Molecular Biosciences 11: 1505255. https://doi.org/10.3389/fmolb.2024.1505255.

Harvard

Shi, J. et al. (2024) ‘Precision-engineered PROTACs minimize off-tissue effects in cancer therapy’, Frontiers in Molecular Biosciences, 11, p. 1505255. doi:10.3389/fmolb.2024.1505255.

IEEE

J. Shi et al., “Precision-engineered PROTACs minimize off-tissue effects in cancer therapy,” Frontiers in Molecular Biosciences, vol. 11, p. 1505255, 2024, doi: 10.3389/fmolb.2024.1505255.

BibTeX

@article{shi2024precision,
  title     = {{Precision-engineered PROTACs minimize off-tissue effects in cancer therapy}},
  author    = {Shi, Jianghua and Wang, Luo and Zeng, Xuanwei and Xie, Chengzhi and Meng, Zhaowei and Campbell, Anahit and Wang, Lulu and Fan, Heli and Sun, Huabing},
  journal   = {Frontiers in Molecular Biosciences},
  year      = {2024},
  volume    = {11},
  pages     = {1505255},
  doi       = {10.3389/fmolb.2024.1505255},
  url       = {https://doi.org/10.3389/fmolb.2024.1505255}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
20251313
20262626

Its field-weighted citation impact is 1.30: it has been cited 1.30 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • protein degradation
  • ubiquitin-proteasome system
  • PEGylation
  • nanotechnology
  • cancer therapy toxicity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Shi, J., Wang, L., Zeng, X., Xie, C., Meng, Z., Campbell, A., Wang, L., Fan, H., & Sun, H. (2024). Precision-engineered PROTACs minimize off-tissue effects in cancer therapy. Frontiers in Molecular Biosciences, 11, 1505255. https://doi.org/10.3389/fmolb.2024.1505255

How many times has this paper been cited?

40 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Molecular Biosciences: sign in and open the full text from this page.

Who wrote this paper?

Jianghua Shi, Luo Wang, Xuanwei Zeng, Chengzhi Xie, Zhaowei Meng, Anahit Campbell, Lulu Wang, Heli Fan, Huabing Sun.

What is the DOI of this paper?

10.3389/fmolb.2024.1505255, permanently at https://doi.org/10.3389/fmolb.2024.1505255. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.